In summary, a number of prospective studies pointed towards a relevance of Lp(a) as relevant CV risk factor in CKD and dialysis patients predicting both, the development of atherosclerotic lesions and adverse outcomes. This evidence concerns the gene LPA and chronic kidney disease.